Primary Objectives
- Align understanding on the outcomes from the Diagnostics and Therapeutics Working Group
- Information sharing of the initial insights from the ACT-A evaluation
- Information sharing on the direction for ACT-A’s plan of work for the next 6 months
Draft agenda
Outcomes from the Diagnostics and Therapeutics Working Group
Ian Dalton, United Kingdom, Working Group Co-Chair
- Q&A
Initial insights from the ACT-A Evaluation
Dr Marco Schäferhoff, Managing Director, Open Consultants
- Q&A
ACT-A in the next phase: Major directions for ACT-A’s plan of work for the next 6 months
Michaela Pfeiffer, ACT-A Hub
- Q&A